<DOC>
	<DOCNO>NCT03092427</DOCNO>
	<brief_summary>This study investigate efficacy probiotic VSL # 3 add standard care activity disease patient Juvenile Idiopathic Arthritis .</brief_summary>
	<brief_title>Probiotic Treatment Juvenile Idiopathic Arthritis ( JIA )</brief_title>
	<detailed_description>Juvenile Idiopathic Arthritis ( JIA ) frequent rheumatic disorder child . Numerous study suggest alteration intestinal barrier may induce abnormal immune response implicate development persistence arthritis . This pave way new therapeutic option aim reestablish intestinal homeostasis treat arthritis prevent disease flare . This study investigate efficacy probiotic VSL # 3 add standard care activity disease patient Juvenile Idiopathic Arthritis .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Juvenile</mesh_term>
	<criteria>Age â‰¥1year &lt; 7years Patients oligoarthritis polyarthritis rheumafactor negative antinuclear antibody ( ANA ) positive JIA onset age 6 year Change JIA forme</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>